Sarah Pearson

机构：University of Oxford, Science Oxford · ORCID：0000-0001-5386-1953

发表论文 34 篇 · 总被引 1417 次 · h-index 16

代表论文

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial (2014 · The Lancet Oncology · 被引 334)
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study (2023 · The Lancet Oncology · 被引 184)
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial (2016 · The Lancet Oncology · 被引 149)
Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood (2015 · Journal of Allergy and Clinical Immunology · 被引 120)
Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial (2022 · British journal of surgery · 被引 85)
Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement (2020 · British Journal of Cancer · 被引 45)